secobarbital will lessen the extent or effect of cannabidiol by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely. Consider a rise in cannabidiol dosage (depending on clinical response and tolerability) when coadministered with a solid CYP3A4 inducer.secobarbital will reduce the extent or effect of alprazolam by